2017
DOI: 10.1097/mlr.0000000000000464
|View full text |Cite
|
Sign up to set email alerts
|

Adjustment for Variable Adherence Under Hierarchical Structure

Abstract: Background Variable adherence to assigned conditions is common in randomized clinical trials. Objectives A generalized modeling framework under longitudinal data structures is proposed for regression estimation of the causal effect of variable adherence on outcome, with emphasis upon adjustment for unobserved confounders. Research Design A nonlinear, nonparametric random-coefficients modeling approach is described. Estimates of local average treatment effects among compliers can be obtained simultaneously … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…Because of this deception ( fabrication ) and poor overall adherence, valid conclusions could only be made in 6 out of 34 patients. In intention-to-treat analyses, undetected non-adherence may lead to biased estimates of treatment effects when analyses are misinterpreted as assessments of treatment as received(16). Rebound effects (due to sudden uncounteracted physiologic responses to the actions of the withdrawn drug) and recurrent first dose effects from drug holidays may confound efficacy and side effects of a new drug(17).…”
Section: Introductionmentioning
confidence: 99%
“…Because of this deception ( fabrication ) and poor overall adherence, valid conclusions could only be made in 6 out of 34 patients. In intention-to-treat analyses, undetected non-adherence may lead to biased estimates of treatment effects when analyses are misinterpreted as assessments of treatment as received(16). Rebound effects (due to sudden uncounteracted physiologic responses to the actions of the withdrawn drug) and recurrent first dose effects from drug holidays may confound efficacy and side effects of a new drug(17).…”
Section: Introductionmentioning
confidence: 99%